Search for a Medicine

  • Medicines
 
 

Showing 221-240 of 512 matching medicines

Product listings were last updated on 05/12/2023
Trade Name Licence Number & Holder Documents
Revatio
Powder for oral suspension

Compare
EU/1/05/318/003
Authorised: 21/03/2012
Upjohn EESV
SPC PIL IPAR
REVAXIS Suspension for injection in pre-filled syringe Diphtheria, tetanus and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
Suspension for injection in pre-filled syringe

Compare
PA2131/007/001
Authorised: 18/02/2000
Sanofi Pasteur
SPC PIL
Revestive
Powder and solvent for solution for injection

Compare
EU/1/12/787/001

Takeda Pharmaceuticals International AG Ireland Branch
SPC PIL IPAR
Revestive
Powder and solvent for solution for injection

Compare
EU/1/12/787/003
Authorised: 23/06/2017
Takeda Pharmaceuticals International AG Ireland Branch
SPC PIL IPAR
Revinty Ellipta
Inhalation powder, pre-dispensed

Compare
EU/1/14/929/001-003
Authorised: 17/06/2014
GlaxoSmithKline (Ireland) Limited
SPC PIL IPAR
Revinty Ellipta
Inhalation powder, pre-dispensed

Compare
EU/1/14/929/004-006
Authorised: 17/06/2014
GlaxoSmithKline (Ireland) Limited
SPC PIL IPAR
Revlimid
Capsule, hard

Compare
EU/1/07/391/001

Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Revlimid
Capsule, hard

Compare
EU/1/07/391/002
Authorised: 14/06/2007
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Revlimid
Capsule, hard

Compare
EU/1/07/391/003
Authorised: 14/06/2007
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Revlimid
Capsule, hard

Compare
EU/1/07/391/004
Authorised: 14/06/2007
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Revlimid
Capsule, hard

Compare
EU/1/07/391/005
Authorised: 10/09/2012
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Revlimid
Capsule, hard

Compare
EU/1/07/391/006
Authorised: 10/09/2012
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Revlimid
Capsule, hard

Compare
EU/1/07/391/009
Authorised: 19/02/2015
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR EdM
Revolade
Film-coated tablet

Compare
EU/1/10/612/007-009
Authorised: 19/09/2013
Novartis Europharm Limited
SPC PIL IPAR
Revolade
Powder for oral suspension

Compare
EU/1/10/612/013
Authorised: 04/04/2016
Novartis Europharm Limited
SPC PIL IPAR
Revolade
Film-coated tablet

Compare
EU/1/10/612/1-3

Novartis Europharm Limited
SPC PIL IPAR
Revolade
Film-coated tablet

Compare
EU/1/10/612/4-6
Authorised: 11/03/2010
Novartis Europharm Limited
SPC PIL IPAR
Reyataz
Oral powder

Compare
EU/1/03/267/012
Authorised: 21/06/2016
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR
Reyataz
Capsule, hard

Compare
EU/1/03/267/01-7

Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR
Reyataz
Capsule, hard

Compare
EU/1/03/267/8-9
Authorised: 17/04/2008
Bristol-Myers Squibb Pharma EEIG
SPC PIL IPAR